Tiny study checks how drug balloon releases medicine in leg arteries
NCT ID NCT06065345
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at how a special balloon coated with a drug called sirolimus derivative releases medication into the blood after being used to open blocked leg arteries. Six people with peripheral artery disease took part. The goal was to measure drug levels over time, not to test if the balloon works better than others.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
sirolimus derivative (BIOtorcin)
What this could lead to
If successful, this could help confirm that the drug-coated balloon delivers medication safely and predictably, supporting its use in treating peripheral artery disease.
What could go wrong
This is a very small, early-stage study with only 6 participants, focused on drug levels in the blood, not on whether the treatment actually improves symptoms or prevents artery reblockage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Royal Perth Hospital
Perth, WAUS, Australia